Related Experiment Video

Updated: Mar 14, 2026

Cardiac Response to β-Adrenergic Stimulation Determined by Pressure-Volume Loop Analysis
08:05

Cardiac Response to β-Adrenergic Stimulation Determined by Pressure-Volume Loop Analysis

Published on: May 19, 2021

4.2K

A meta-analysis of the effects of β-adrenergic blockers in chronic heart failure

Xiaojian Zhang1, Chengwu Shen1, Shujun Zhai1

  • 1Shandong Provincial Hospital Affiliated to Shandong University, Ji'nan, Shandong 250021, P.R. China.

Experimental and Therapeutic Medicine
|October 6, 2016
PubMed

Insights

Beta-blockers significantly reduce mortality in heart failure patients, even those with complex conditions. This meta-analysis confirms their beneficial effects on reducing long-term mortality and sudden cardiac death in heart disease.

Area of Science:

  • Cardiology
  • Pharmacology

Background:

  • Adrenergic β-blockers are crucial medications that block β-adrenergic receptors.
  • They are widely used for conditions including hypertension, angina, and heart failure.
  • Previous meta-analyses suggest β-blockers improve cardiac function and reduce cardiovascular events in chronic heart failure (CHF).

Purpose of the Study:

  • To conduct a meta-analysis evaluating the efficacy of β-blockers on mortality and morbidity in heart failure patients.
  • To synthesize findings from recent meta-analyses on β-adrenergic blockers in CHF.

Main Methods:

  • Searched databases (Medline, Embase, CENTRAL, PubMed) for relevant studies.
  • Included studies published between May 1985–March 2011 and June 2013–August 2015.
  • Synthesized results from identified meta-analyses.

Main Results:

  • β-blocker use was associated with decreased sudden cardiac death in heart failure patients.
  • Mortality was significantly reduced with β-blocker treatment, including pre-surgery.
  • Long-term mortality decreased significantly, even in patients meeting MERIT-HF exclusion criteria.

Conclusions:

  • β-blocker treatment demonstrates significant benefits for heart failure patients.
  • These drugs effectively reduce mortality and morbidity in patients with heart failure and related heart diseases.
  • Findings support the continued use of β-blockers in managing heart failure.

Keywords:
chronic heart failureβ-adrenergicβ-blockers

More Related Videos

Implantation of an Isoproterenol Mini-Pump to Induce Heart Failure in Mice05:08

Implantation of an Isoproterenol Mini-Pump to Induce Heart Failure in Mice

Published on: October 3, 2019

12.0K
Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure05:16

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure

Published on: June 10, 2025

741

Related Concept Videos

Heart Failure Drugs: β-Blockers01:22

Heart Failure Drugs: β-Blockers

β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
1.1K
Adrenergic Antagonists: Pharmacological Actions of β-Receptor Blockers01:27

Adrenergic Antagonists: Pharmacological Actions of β-Receptor Blockers

β-receptor blockers significantly impact the cardiovascular system by counteracting catecholamine-induced sympathetic responses. These medications decrease heart rate, contractility, and cardiac output, potentially leading to cardiac depression, life-threatening bradycardia, and death. Therapeutically, β-blockers function as mild antihypertensives and are utilized in treating angina pectoris and cardiac arrhythmias. However, nonselective β-blockers inhibit β2-receptors in...
1.9K
Antihypertensive Drugs: Types of β-Blockers01:28

Antihypertensive Drugs: Types of β-Blockers

β receptors are classified into three subclasses: β1, β2, and β3. β1 receptors are primarily located in the heart and kidneys. When they get activated, they increase heart rate, contractility, and renin release. This process enhances blood pressure and aids in stress management. In contrast, β2 receptors are situated mainly in the lungs, blood vessels, and skeletal muscles. Upon activation, they trigger smooth muscle relaxation, causing bronchodilation and...
1.9K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
1.3K
Adrenergic Antagonists: Chemistry and Classification of β-Receptor Blockers01:25

Adrenergic Antagonists: Chemistry and Classification of β-Receptor Blockers

β-adrenergic antagonists, or β-blockers, modulate the sympathetic nervous system by targeting β-adrenoceptors and inhibiting catecholamine-mediated sympathetic responses. β-blockers differ in their adrenoceptor subtype affinity, lipophilicity, and α-blocking capabilities. The history of β-blocker development began with the prototype, dichloroisoprenaline, which exhibited partial agonist activity. As a result, propranolol was developed as a pure antagonist but...
1.6K
Antihypertensive Drugs: Action of β1 Blockers01:17

Antihypertensive Drugs: Action of β1 Blockers

β1-receptors are primarily located in the heart and kidneys. In cardiac myocytes, these receptors interact with neurotransmitters released by the sympathetic nervous system during heightened activity or danger. As a result, β1-receptors get activated, initiating a series of biochemical processes. Excessive activation of beta receptors due to chronic stress can abnormally increase heart rate and contractility, resulting in high blood pressure or hypertension. To counteract this,...
2.2K